Cognitive Deterioration
17
1
1
10
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
17.6%
3 terminated out of 17 trials
76.9%
-9.6% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (17)
Brain Health Together: A Live-Streaming Group-Based Digital Program
Normative Database and Test-Retest Reliability for BrainCheck Assessments
Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome
Objective Measurement of Pain in Individuals With Cognitive Deterioration Utilizing Electroencephalography
Pain Management in Elderly Patients With or Without Cognitive Frailty Hospitalized "ALGOGER"
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Effects of Petroleum Compounds on Psychological Health and Cognitive Functions
Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
Safe & Easy for Alzheimer's Disease and Related Pathologies
Effects of rhLactoferrin on Chronic Inflammation in the Elderly
Personalized Virtual Reality Naturalistic Scenarios in Cognitive Impairment
Network-based rTMS in Alzheimer's Disease
Swiss SOS MoCA - DCI Study
Exercise, Age-Related Memory Decline, And Hippocampal Function
Effects of Acute Hypobaric Hypoxia Exposure on Neurocognitive Performance of Pre-hospital Emergency Service Providers
Preoperative Cognitive Training for Postoperative Cognitive Dysfunction
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)